Genfit SA (GNFT)
3.52
+0.02
(+0.57%)
USD |
NASDAQ |
May 01, 16:00
3.52
0.00 (0.00%)
After-Hours: 20:00
Genfit Enterprise Value: 159.60M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 159.60M |
| April 29, 2024 | 160.60M |
| April 26, 2024 | 159.10M |
| April 25, 2024 | 157.11M |
| April 24, 2024 | 159.10M |
| April 23, 2024 | 156.85M |
| April 22, 2024 | 167.58M |
| April 19, 2024 | 155.11M |
| April 18, 2024 | 164.09M |
| April 17, 2024 | 166.08M |
| April 16, 2024 | 166.08M |
| April 15, 2024 | 160.60M |
| April 12, 2024 | 163.60M |
| April 11, 2024 | 167.58M |
| April 10, 2024 | 167.99M |
| April 09, 2024 | 163.09M |
| April 08, 2024 | 157.60M |
| April 05, 2024 | 161.01M |
| April 04, 2024 | 165.33M |
| April 03, 2024 | 167.08M |
| April 02, 2024 | 163.09M |
| April 01, 2024 | 162.59M |
| March 28, 2024 | 162.50M |
| March 27, 2024 | 166.98M |
| March 26, 2024 | 167.98M |
| Date | Value |
|---|---|
| March 25, 2024 | 168.23M |
| March 22, 2024 | 168.48M |
| March 21, 2024 | 165.99M |
| March 20, 2024 | 166.48M |
| March 19, 2024 | 155.52M |
| March 18, 2024 | 160.50M |
| March 15, 2024 | 160.50M |
| March 14, 2024 | 158.51M |
| March 13, 2024 | 163.49M |
| March 12, 2024 | 161.00M |
| March 11, 2024 | 163.00M |
| March 08, 2024 | 165.58M |
| March 07, 2024 | 162.75M |
| March 06, 2024 | 161.59M |
| March 05, 2024 | 162.00M |
| March 04, 2024 | 167.98M |
| March 01, 2024 | 165.49M |
| February 29, 2024 | 158.01M |
| February 28, 2024 | 171.66M |
| February 27, 2024 | 168.64M |
| February 26, 2024 | 166.98M |
| February 23, 2024 | 167.48M |
| February 22, 2024 | 171.47M |
| February 21, 2024 | 163.99M |
| February 20, 2024 | 162.70M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-62.99M
Minimum
Jun 13 2022
904.96M
Maximum
May 06 2019
209.83M
Average
137.01M
Median
May 26 2023
Enterprise Value Benchmarks
| Cellectis SA | 147.83M |
| Biophytis SA | 2.523M |
| DBV Technologies SA | -13.23M |
| Edap TMS SA | 219.81M |
| Adaptimmune Therapeutics PLC | 145.80M |
Enterprise Value Related Metrics
| Revenue (Quarterly) | 15.36M |